Promonitor
The Promonitor family of tests measures both drug levels and anti-drug antibody levels with validated ELISA assays to complement biological therapies for drug monitoring. Testing for drug bioavailability and immunogenicity: IFX, Anti-IFX, ADL, Anti-ADL, RTX, Anti-RTX, ETN, Anti-ETN, GLM, Anti-GLM, VDZ, Anti-VDZ, UTK, Anti-UTK.
OVERVIEW
Optimize Therapy
Refine treatment of chronic inflammatory diseases with a personalized approach to therapy with biologics.
- Individualized treatment for every patient, enabling a personalized approach to therapy with biologics
- Early information about reduced drug efficacy – Promonitor provides an early warning if the treatment regime may require modification
Cost Effective
Reduce the use of ineffective treatment strategies, allowing a more efficient use of available resources.
- Effectively manage resources with the information provided by Promonitor
Easy to Use
Quickly generate results with ELISA-based tests and readily available equipment.
- Quick procedure – 4 simple steps
- Hands-on time – 30 min
- Microplate precoated and ready-to-use reagents
- Easy data interpretation
Flexible
Expand lab operations and workflow with multiple tests and configurations.
- Removable strips allow multiple configurations
- Test both drug levels and anti-drug antibody levels
- Manual or automated mode
High Quality
Rely on results with a high quality product.
- High specificity and sensitivity
- Supported by a large number of peer-reviewed articles
- More than 100 publications using Promonitor.
Monitoring Biosimilars
Evaluation studies have demonstrated that Promonitor kits are able to quantify not only biological drug levels, but also biosimilar drugs.
